Last edition
News about "INBRIJA"
Merz Therapeutics and Kvvit Sign China Deal for INBRIJA Parkinson's Therapy
Merz Therapeutics and Kvvit sign an exclusive agreement for commercialization of INBRIJA in mainland China, Hong Kong, and Macao, expanding access to advanced treatment options for Parkinson's disease patients.
INBRIJA | 26/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members